Why the study?
Does cardiovascular magnetic resonance improve the evaluation, risk stratification, and management of patients with aortic valve disease?
Does cardiovascular magnetic resonance improve the evaluation, risk stratification, and management of patients with aortic valve disease?
CMR is a comprehensive, all-in-one imaging modality for the evaluation, risk stratification, and treatment planning of aortic valve disease.
May support CMR integration into aortic valve workflows; leaves open need for outcome trials before routine adoption.
Cardiovascular magnetic resonance (CMR) has an emerging role in aortic valve disease evaluation, becoming an all-in-one technique. CMR evaluation of the anatomy and flow through the aortic valve has a higher reproducibility than echocardiography. Its unique ability of in vivo myocardial tissue characterization, significantly improves the risk stratification and management of patients. In addition, CMR is equivalent to cardiac CT angiography for trans-aortic valvular implantation and surgical aortic valve replacement planning; on the other hand, its role in the evaluation of ventricular function improving and post-treatment complications is undisputed. This review encompasses the existing literature regarding the role of CMR in aortic valve disease, exploring all the aspects of the disease, from diagnosis to prognosis.
No takes yet. Share an insight, caveat, or question.
Rubeis et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: